Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust Plc LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 632.00 632.00 634.00 636.00 632.00 632.00 49,382 16:28:53
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -2.5 -6.9 - 241

International Biotechnol... Share Discussion Threads

Showing 401 to 423 of 500 messages
Chat Pages: 20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
16/7/2015
07:40
A nice run here and in the sector generally
rathlindri
13/4/2015
09:17
Amazing that still at approx 8% discount to NAV!!
gargleblaster
13/4/2015
07:20
Bouncing back?
rathlindri
22/3/2015
07:57
Yep. Good sector not subject to deflationary pressures and very exciting future discoveries.
philo124
21/3/2015
20:48
Took a small holding here on friday morning, hopefully not too late! Have done well with the Axa Framlington Biogen unit trust fund over the last 12 months and I see quite an overlap in share holdings here....best of luck to us all
rathlindri
06/3/2015
01:22
Amazing - I think the last little uplift is because 3% of the IBT portfolio was invested in Pharmacyclics which has just been taken-over by Abbvie. Although the takeout was not at a massive premium to the share price it puts a huge future premium on the value of its Imbruvica drug. RBC Capital analyst Michael Yee said AbbVie is paying seven times the projected Imbruvica peak sales of $6bn – more than any recent takeover of a biotech firm. He explained: “There is scarcity value for drugs that ‘move the needle’ and those command a premium.” Things are getting even hotter in the biotech space!
gargleblaster
06/3/2015
00:37
Outstanding; 150% gain in 12 months!
philo124
23/1/2015
17:00
Ibt, biog, wwh; wish I had not taken profits on the way up. What great funds to have in your portfolio.
philo124
23/1/2015
11:26
Amazing run - i just topped up yesterday which seems a bit crazy - but perhaps not so mad looking a couple of years down the track (and still a slight discount to nav).
gargleblaster
23/1/2015
10:32
Marvellous
luckymouse
08/1/2015
08:22
Up 50% in 3 months and discount has narrowed from c25%.
philo124
08/1/2015
08:17
Still at over 10% discount to NAV but gap is closing and NAV is on a positive trend. One of my favourites in an exciting sector. Hopefully 2015 will be as good as 2014 and the trend continues...
barnold
19/12/2014
12:58
Just noticed that the NAV is up by over 4% since yesterday!
gargleblaster
19/12/2014
12:56
Thanks for that Peter. Going gangbusters at the moment!
gargleblaster
19/12/2014
10:38
They are allowing unquoted investments to come to their natural end while making follow-on investments as may be appropriate but have said that they will pause entering any new unquoted companies. This is part of employing a more risk averse strategy and avoiding binary events. They think that the average 12% discount is 6% in line with the market and 6% because the market is attributing a 50% discount to the unquoted portion of the portfolio. This not mathematically exact but you get the idea. A widening discount will see more buy-backs but this will increase the unquoted weighting. They see more M & A and IPO exits. The management fee will fall from 1.15% to 0.9% wef 1 March 2015 to reflect the lower requirements to monitor uq investments.
peter27
18/12/2014
21:59
More tomorrow with the Dow up 700 points!
philo124
18/12/2014
21:48
PS - the portfolio update today would only account for about a 1.2% increase in the NAV (5.7p), a relatively small part of today's rise.
gargleblaster
18/12/2014
21:36
Interesting Peter. Are you saying that they divested out of the unquoted's and re-invested back into the quoted's and this then gives a nudge up to the NAV? Any thing else of interest come up at the agm? Thanks for the above, and in advance for any further info.
gargleblaster
18/12/2014
18:17
At the AGM they said that they have decided to cease new unquoted investments on the basis that they are too speculative. An interesting decision considering that today's news has probably driven the price as it has added to NAV.
peter27
18/12/2014
17:48
New closing high - glad I did not take any cash off the table now!
gargleblaster
29/11/2014
17:15
It will be very interesting to be able to question them at the AGM in two weeks time.
peter27
29/11/2014
15:21
No I haven't but your summary is interesting and I will look out for it.
philo124
29/11/2014
07:45
Phil - Have you read Jim Mellon's book "Cracking the code" - great read about the potential of Biotech. One of his main points is that governments around the world cannot afford to fund our aging populations and therefore are putting more faith/dependency on healthcare and biotech sectors - i.e. they need to get the drugs approved and they are on the side of the sector - not putting barriers in the way. So probably not recession proof but people will always need treatment, drugs etc.
gargleblaster
Chat Pages: 20  19  18  17  16  15  14  13  12  11  10  9  Older
Your Recent History
LSE
IBT
Internatio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191211 03:18:52